Mariner’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,931
Closed -$1.04M 1100
2019
Q2
$1.04M Buy
7,931
+213
+3% +$27.5K 0.01% 529
2019
Q1
$1.04M Buy
7,718
+3,246
+73% +$404K 0.01% 485
2018
Q4
$435K Sell
4,472
-758
-14% -$89.6K 0.01% 602
2018
Q3
$727K Sell
5,230
-969
-16% -$122K 0.02% 490
2018
Q2
$770K Buy
+6,199
New +$724K 0.02% 457
2018
Q1
Sell
-4,813
Closed -$576K 705
2017
Q4
$576K Buy
4,813
+113
+2% +$13.8K 0.02% 373
2017
Q3
$659K Sell
4,700
-373
-7% -$50.7K 0.03% 304
2017
Q2
$617K Sell
5,073
-278
-5% -$32.4K 0.03% 307
2017
Q1
$649K Sell
5,351
-846
-14% -$109K 0.03% 342
2016
Q4
$758K Buy
6,197
+372
+6% +$45.5K 0.03% 305
2016
Q3
$714K Buy
5,825
+135
+2% +$17.4K 0.03% 308
2016
Q2
$664K Sell
5,690
-4,378
-43% -$621K 0.04% 290
2016
Q1
$1.4M Buy
10,068
+1,508
+18% +$221K 0.08% 199
2015
Q4
$1.63M Sell
8,560
-3,115
-27% -$544K 0.1% 165
2015
Q3
$1.83M Buy
11,675
+415
+4% +$75.7K 0.08% 177
2015
Q2
$2.04M Buy
11,260
+1,476
+15% +$255K 0.09% 176
2015
Q1
$1.7M Buy
9,784
+2,150
+28% +$389K 0.14% 121
2014
Q4
$1.41M Sell
7,634
-1,354
-15% -$251K 0.13% 141
2014
Q3
$1.49M Buy
8,988
+115
+1% +$18.9K 0.17% 110
2014
Q2
$1.39M Buy
8,873
+2,838
+47% +$448K 0.15% 125
2014
Q1
$918K Buy
6,035
+645
+12% +$103K 0.12% 158
2013
Q4
$716K Buy
5,390
+2,085
+63% +$250K 0.09% 183
2013
Q3
$384K Buy
+3,305
New +$363K 0.07% 213

Other funds holding ALXN